| scholarly article | Q13442814 |
| P2093 | author name string | Jing Zhao | |
| Chao Wang | |||
| Xian Yu | |||
| Guang-Yao Song | |||
| Lu-Ping Ren | |||
| Han-Ying Xing | |||
| Ya-Jun Zhu | |||
| P2860 | cites work | XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor | Q24292102 |
| Fructose, insulin resistance, and metabolic dyslipidemia | Q24556527 | ||
| IRE1-mediated unconventional mRNA splicing and S2P-mediated ATF6 cleavage merge to regulate XBP1 in signaling the unfolded protein response | Q24672592 | ||
| Signal integration in the endoplasmic reticulum unfolded protein response | Q27860577 | ||
| IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA | Q28214814 | ||
| Intracellular signaling by the unfolded protein response | Q28250477 | ||
| Regulation of hepatic lipogenesis by the transcription factor XBP1 | Q28507784 | ||
| Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis | Q28508851 | ||
| Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes | Q28575190 | ||
| XBP1 controls diverse cell type- and condition-specific transcriptional regulatory networks | Q28591575 | ||
| Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease | Q29619334 | ||
| Hepatic Bax inhibitor-1 inhibits IRE1alpha and protects from obesity-associated insulin resistance and glucose intolerance | Q33673551 | ||
| Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes | Q33878155 | ||
| XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation | Q34345459 | ||
| Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes? | Q34924188 | ||
| Pharmacological ER stress promotes hepatic lipogenesis and lipid droplet formation | Q35747483 | ||
| Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition | Q36734305 | ||
| Endoplasmic reticulum stress markers are associated with obesity in nondiabetic subjects | Q36971939 | ||
| Endoplasmic reticulum stress is reduced in tissues of obese subjects after weight loss | Q37105351 | ||
| GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice | Q37170811 | ||
| Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease | Q37310283 | ||
| The role of the lipogenic pathway in the development of hepatic steatosis. | Q37386081 | ||
| The adaptive endoplasmic reticulum stress response to lipotoxicity in progressive human nonalcoholic fatty liver disease | Q37412003 | ||
| The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome | Q37724585 | ||
| Endoplasmic reticulum stress: a new actor in the development of hepatic steatosis. | Q37750327 | ||
| Nonalcoholic steatohepatitis: the therapeutic challenge of a global epidemic | Q37946188 | ||
| Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis | Q38073225 | ||
| A long-lasting dipeptidyl peptidase-4 inhibitor, teneligliptin, as a preventive drug for the development of hepatic steatosis in high-fructose diet-fed ob/ob mice | Q38288859 | ||
| Endoplasmic Reticulum Stress Response in Non-alcoholic Steatohepatitis: The Possible Role of Physical Exercise | Q38403149 | ||
| Endoplasmic reticulum stress and Oxidative stress in the pathogenesis of Non-alcoholic fatty liver disease | Q38557011 | ||
| Genetic and epigenetic mechanisms of NASH. | Q38673496 | ||
| The IRE1alpha-XBP1 pathway of the unfolded protein response is required for adipogenesis | Q39843795 | ||
| Gastric bypass surgery is protective from high-fat diet-induced non-alcoholic fatty liver disease and hepatic endoplasmic reticulum stress | Q40216244 | ||
| UPR pathways combine to prevent hepatic steatosis caused by ER stress-mediated suppression of transcriptional master regulators. | Q42041480 | ||
| Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans | Q44602540 | ||
| The chemical chaperon 4-phenylbutyric acid ameliorates hepatic steatosis through inhibition of de novo lipogenesis in high-fructose-fed rats | Q44638833 | ||
| Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. | Q45917922 | ||
| Diet high in fructose promotes liver steatosis and hepatocyte apoptosis in C57BL/6J female mice: Role of disturbed lipid homeostasis and increased oxidative stress | Q47841256 | ||
| Long-term administration of tacrolimus and everolimus prevents high cholesterol-high fructose-induced steatosis in C57BL/6J mice by inhibiting de-novo lipogenesis | Q49438485 | ||
| Schisandra chinensis extract ameliorates nonalcoholic fatty liver via inhibition of endoplasmic reticulum stress. | Q52880890 | ||
| Protective Effect of Gomisin N against Endoplasmic Reticulum Stress-Induced Hepatic Steatosis. | Q52885453 | ||
| Role of human liver lipogenesis and reesterification in triglycerides secretion and in FFA reesterification | Q74254882 | ||
| P433 | issue | 19 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2310-2319 | |
| P577 | publication date | 2018-10-05 | |
| P1433 | published in | Chinese Medical Journal | Q5100534 |
| P1476 | title | Role of X-Box Binding Protein-1 in Fructose-Induced Lipogenesis in HepG2 Cells | |
| P478 | volume | 131 |
| Q90049531 | Endoplasmic reticulum stress may be involved in insulin resistance and lipid metabolism disorders of the white adipose tissues induced by high-fat diet containing industrial trans-fatty acids |
| Q99545179 | β-catenin mediates the effect of GLP-1 receptor agonist on ameliorating hepatic steatosis induced by high fructose diet |
Search more.